Clinical Trial Update: VPD-737 for Treatment of Chronic Pruritus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for VPD-737 in chronic pruritus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pruritus

Drugs mentioned

• VPD-737

Snippet

Sponsor: Vyne Therapeutics Inc. | Conditions: Chronic Pruritus | Phase 2 | Status: COMPLETED